Comparison of vasorelaxing actions of vasonatrin peptide, C-type natriuretic peptide and atrial natriuretic peptide

Acta Physiologica Sinica

Volumn 51, Issue 5, 1999, Pages 515-520

  Feng, Hua Song ^a,d   Zang, Yi Min ^b   Zhu, Miao Zhang ^b   Pei, Jian Ming ^b   Wang, Yue Min ^b   Wang, Lin ^a   Shi, Pu Tao ^c  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^d BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Atrial natriuretic peptide; C type natriuretic peptide; Rat; Vasodilation; Vasonatrin peptide

Indexed keywords

ATRIAL NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; VASODILATOR AGENT; VENTRICULAR NATRIURETIC PEPTIDE, EEL;

ABDOMINAL AORTA; ANIMAL; ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; IN VITRO STUDY; MALE; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; AORTA, ABDOMINAL; ATRIAL NATRIURETIC FACTOR; ENDOTHELIUM, VASCULAR; MALE; NATRIURETIC PEPTIDE, C-TYPE; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION; VASODILATOR AGENTS;

EID: 0039182043     PISSN: 03710874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Garcia R, Thibault G, Cantin M, et al. Effects of a purified natriuretic factor on rat and rabbit vascular strips and vascular beds. Am J Physiol, 1984, 247: R34-R39.
2. Suddo T, Minamino N, Kangawa K, et al. C-type natriuretic peptide (CNP): a new member of the natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun, 1990, 168: 863-870.
3. Wei CM, Kim CH, Miller VM. et al. Vasonatrin peptide: A unique synthetic natriuretic and vasorelaxing peptide. J Clin Invest, 1993, 92: 2048-2052.
4. de Bold AJ, Borenstein HB, Veress AT, et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci, 1981, 28: 89-94.
5. Kenny AJ, Bourne A, Ingran J. Hydrolysis of pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase 24.11. Biochem J, 1993, 291: 83-88.
6. Zhang LM, Castresana MR, Mcdonald MH, et al. Response of human artery, vein, and cultured smooth muscle to atrial and C-type natriuretic peptides. Crit Care Med, 1996, 24: 306-310.
7. Currie MG, Geller DM, Cole BR, et al. Purification and sequence analysis of bioactive atrial peptides (atriopeptins). Science, 1984, 223: 67-69.
8. Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptides and their receptors. Circulation, 1992, 86: 1081-1088.
9. Wilcox JN, Augustine A, Goeddel DV, et al. Differential regional expression of three natriuretic peptide receptor genes within primate tissues. Mol Cell Biol, 1991, 11: 3454-3462.
10. Suga S, Nakao K, Kishimoto I, et al. Phenotype-related alteration in expression of natriuretic peptide receptor in aortic smooth muscle cells. Circ Res, 1992, 71: 34-39.